Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer Meeting Abstract
| Authors: | Montemurro, F.; Prat, A.; Rossi, V.; Valabrega, G.; Sperinde, J.; Peraldo-Neia, C.; Donadio, M.; Galvan, P.; Sapino, A.; Aglietta, M.; Baselga, J.; Scaltriti, M. |
| Abstract Title: | Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496900198 |
| DOI: | 10.1158/0008-5472.sabcs13-p1-08-23 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1-08-23 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
